Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
RPGLIFE
₹2,638
₹2610.00
₹2666.20
₹1733.00
₹3082.00
Markets Today
Historical Performance
As of 25-08-2026 00:50, RPG Life Sciences Ltd. share price today is ₹0, with a change of ₹-2636.60 (-100.00%) from the previous close of ₹2636.6. The stock opened at ₹2636.6 and traded between ₹2610 and ₹2666.2, with a total traded volume of 9098 shares. The company has a market capitalization of ₹4360.7 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹3082 and ₹1733, respectively.
RPG Life Sciences Ltd. valuation metrics include a P/E ratio of 36.4, EPS of ₹69.64, and book value of ₹6.90. Profitability indicators show ROE of 19.02% along with a dividend yield of 0.9%. RPG Life Sciences Ltd. has reported revenue of ₹734.29 Cr and net profit of ₹119.64 Cr.
RPG Life Sciences Ltd. technical indicators include Day RSI at 44.42, Day MFI at 47.28, Day ADX at 24.21. Additional indicators include Commodity Channel Index (CCI) at -93.4 and Williams %R at -87.6. Momentum indicators show Day MACD at -3.02, Day MACD Signal Line at 18.18, DayATR at 105.72. Rate of Change indicators for RPG Life Sciences Ltd. include ROC125 at 33.73 and ROC21 at -9.16.
Exponential moving averages include EMA5 at ₹2671.5, EMA10 at ₹2693.2, EMA12 at ₹2699.8, EMA20 at ₹2710.6, EMA26 at ₹2702.9, EMA50 at ₹2620.9, EMA100 at ₹2470.6, EMA200 at ₹2350.3. Simple moving averages include SMA5 at ₹2680.6, SMA10 at ₹2690, SMA20 at ₹2733.7, SMA30 at ₹2795.2, SMA50 at ₹2625.6, SMA100 at ₹2379.1, SMA150 at ₹2245.9, SMA200 at ₹2262.5.
Support levels for RPG Life Sciences are placed at First Support ₹2608.23, Second Support ₹2579.87, Third Support ₹2547.53. Resistance levels are seen at First Resistance ₹2668.93, Second Resistance ₹2701.27, Third Resistance ₹2729.63. RPG Life Sciences Ltd. shareholding pattern shows promoter holding at 72.95%, FII holding at 0.95%, DII holding at 0%, public holding at 17.42%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 195.69 | 176.89 | 180.03 | 181.68 | 168.92 |
| Operating Expense | 152.11 | 144.02 | 140.27 | 142.65 | 133.45 |
| Operating Profit | 43.58 | 32.87 | 39.76 | 39.03 | 35.47 |
| Depreciation | 5.90 | 5.74 | 5.38 | 5.22 | 5.14 |
| Interest | 0.63 | 0.39 | 0.25 | 0.12 | 0.13 |
| Tax | 10.64 | 10.30 | 6.99 | 12.60 | 9.14 |
| Net Profit | 30.57 | 29.90 | 22.13 | 36.85 | 26.29 |
₹2638.00
↗ Bullish Moving Average
7
↘ Bearish Moving Average
9
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 73 | 73 | 73 | 73 | 73 | 73 |
| FII | 1.5 | 1.4 | 1.1 | 1 | 0.9 | 1 |
| DII | 6.1 | 6.4 | 6.7 | 7 | 7.4 | 8.6 |
| Public | 19.5 | 19.2 | 19.2 | 19 | 18.7 | 17.4 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.48 K | 5.16 K | 48.09% |
| Week | 4.57 K | 9.62 K | 47.53% |
| 1 Month | 7.74 K | 17.24 K | 44.88% |
| 6 Month | 10.3 K | 36.78 K | 28.01% |
Benjamin Graham Value Screen
Companies with 10% increase in share price over three months, with rising net profit growth
Expensive Performers (DVM)
Dividend yield greater than sector dividend yield
High Momentum Scores (Technical Scores greater than 50)
Companies with Low Debt
Increasing profits every quarter for the past 2 quarters
Companies with Zero Promoter Pledge
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 09 Jul, 2026 | 24 | FINAL | 09 Jul, 2026 | Equity Share |
| 27 Jun, 2025 | 4 | SPECIAL | 27 Jun, 2025 | Equity Share |
| 27 Jun, 2025 | 20 | FINAL | 27 Jun, 2025 | Equity Share |
| 28 Jun, 2024 | 16 | FINAL | 28 Jun, 2024 | Equity Share |
| 21 Jul, 2023 | 12 | FINAL | 21 Jul, 2023 | Equity Share |
| 14 Jul, 2022 | 9.6 | FINAL | 15 Jul, 2022 | Equity Share |
| 13 Aug, 2021 | 7.2 | FINAL | 17 Aug, 2021 | Equity Share |
| 24 Mar, 2020 | 4 | INTERIM | 26 Mar, 2020 | Equity Share |
| 22 Jul, 2019 | 2.4 | FINAL | Equity Share | |
| 19 Jul, 2018 | 2.4 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹526.25 | ₹6.55 | ₹205.20 | ₹15.46 | ₹30.45 | ₹988 |
| % Change | -2.70% | 4.97% | 4.81% | 8.26% | 1.33% | -0.56% |
| Revenue TTM (₹ Cr) | ₹526.28 | ₹69.99 | ₹291.17 | ₹226.23 | ₹470.86 | ₹942.10 |
| Net Profit TTM (₹ Cr) | ₹20.77 | ₹-176.47 | ₹14.68 | ₹31.63 | ₹25.36 | ₹66.42 |
| PE TTM | 115.10 | -0.30 | 51.80 | 2.40 | 45.30 | 31.40 |
| 1 Year Return | 37.97 | 524 | 55.39 | 56.92 | -4.3 | -1.8 |
| ROCE | 3.56 | -56.37 | - | 17.36 | 7.78 | 15.65 |
Vineet Laboratories Ltd.
₹ 37.00
-2.14%
Solara Active Pharma Sciences Ltd.
₹ 628.00
+1.80%
Zim Laboratories Ltd.
₹ 124.16
-0.70%
Medico Remedies Ltd.
₹ 42.09
-1.31%
Dishman Carbogen Amcis Ltd.
₹ 173.00
-0.31%
Lasa Supergenerics Ltd.
₹ 7.33
+1.81%
Haleos Labs Ltd.
₹ 1500.00
+2.39%
Advanced Enzyme Technologies Ltd.
₹ 302.20
+0.73%
Bajaj Healthcare Ltd.
₹ 322.00
+0.00%
Ortin Global Ltd.
₹ 15.26
-3.96%
Brooks Laboratories Ltd.
₹ 61.70
+2.83%
Bafna Pharmaceuticals Ltd.
₹ 254.55
+4.99%
Alpa Laboratories Ltd.
₹ 61.20
-2.47%
SMS Pharmaceuticals Ltd.
₹ 354.00
-0.73%
Nectar Lifesciences Ltd.
₹ 10.80
+3.15%
Mangalam Drugs and Organics Ltd.
₹ 30.44
+9.97%
Indoco Remedies Ltd.
₹ 220.00
-2.78%
Ind-Swift Laboratories Ltd.
₹ 325.35
-1.29%
Lincoln Pharmaceuticals Ltd.
₹ 612.00
-0.33%
Panacea Biotec Ltd.
₹ 406.50
-1.12%
Medicamen Biotech Ltd.
₹ 234.00
-4.31%
Themis Medicare Ltd.
₹ 120.50
+13.53%
Venus Remedies Ltd.
₹ 1693.10
-2.59%
Bal Pharma Ltd.
₹ 85.00
-1.08%
By signing up I certify terms, conditions & privacy policy